BFRI
Biofrontera Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.61
+6.62%Margins
Gross margin
84.5%
EBITDA margin
-12.2%
EBIT margin
-9.5%
Net margin
-13.8%
FCF margin
-17.2%
-106.9%
Return on equity
-26.5%
Return on assets
-32.4%
Return on invested capital
1.89x
Asset turnover
-$7.9M
Cash from operations
$0.31
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026